Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2009
02/26/2009US20090053831 Tyrosine phosphorylation sites
02/26/2009US20090053830 Blood Test Kit
02/26/2009US20090053829 Absorption pad for immunoassay, strip for immunoassay and immunoassay apparatus
02/26/2009US20090053828 Detection of glycopeptides and glycoproteins for medical diagnostics
02/26/2009US20090053827 Assay device and method
02/26/2009US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers
02/26/2009US20090053825 Molecular recognition polymer enabling reconstruction of recognition field for target molecule and method of producing the same
02/26/2009US20090053822 METHOD AND Pd/V2 O5 DEVICE FOR H2 DETECTION
02/26/2009US20090053820 Two-step nucleic acid testing method using the same sample
02/26/2009US20090053819 Methods and Systems for Protein and Peptide Evidence Assembly
02/26/2009US20090053818 Quantitative proteomics with isotopic substituted raman active labeling
02/26/2009US20090053817 Fixed charge reagents
02/26/2009US20090053816 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders
02/26/2009US20090053815 Use of Holographic Sensors
02/26/2009US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof
02/26/2009US20090053761 Polypeptide Mutagenesis Method
02/26/2009US20090053756 Method for monitoring and promoting the nutrition and well-being as well as the productivity of animals
02/26/2009US20090053754 Assay for Low Molecular Weight Heparin
02/26/2009US20090053746 Fluorescence resonance energy transfer (Fret) on substrates comprising syntaxin or mimetics thereof; for clostridium and tetanus toxins
02/26/2009US20090053743 Anti-antibody reagent
02/26/2009US20090053742 Capture and release based isotope tagged peptides and methods for using the same
02/26/2009US20090053741 Assay for measuring asymmetric methylarginine in a biological sample
02/26/2009US20090053740 Agglutination-based method for fast detection, isolation and quantification of apoptotic cells
02/26/2009US20090053739 Heme Binding Protein (HBP); use in drug screening agents that modulate FPRL2 (Formyl peptide receptor-like 2 )
02/26/2009US20090053738 Protease detection
02/26/2009US20090053737 Monoclonal Antibody Which Binds Met In Formalin-Fixed and Paraffin-Embedded Tissues and Related Methods
02/26/2009US20090053736 Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
02/26/2009US20090053735 Vector expressing n-deacetylase/n-sulfotransferase 2
02/26/2009US20090053734 Identifying antagonists agents that inhibit the function of AM, factor H, or the AM/factor H complex; cancer, diabetes; isolating AM-binding proteins wherein AM is conjugated with a label or marker and incubated with cellular or extracellular lysates
02/26/2009US20090053733 Simultaneous assay for determining drugs
02/26/2009US20090053732 Microfluidic devices, methods and systems for detecting target molecules
02/26/2009US20090053731 Method for Detection of L523S Expression in Biological Samples
02/26/2009US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same
02/26/2009US20090053727 Risk Assessment For Adverse Drug Reactions
02/26/2009US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)
02/26/2009US20090053721 Voltage-gated ion channel mutants for use in identifying ion channel modulating compounds
02/26/2009US20090053717 Methods and compositions for detecting spermatozoa or semen in a sample
02/26/2009US20090053714 Gins gene expression as marker for actively cycling cells and cell cycle phase
02/26/2009US20090053713 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
02/26/2009US20090053712 Methods of using LEDGF/p75
02/26/2009US20090053709 Enhanced sensitivity of a cantilever sensor via specific bindings
02/26/2009US20090053707 Methods for lightening skin and hair
02/26/2009US20090053706 Dna methylation markers associated with the cpg island methylator phenotype (cimp) in human colorectal cancer
02/26/2009US20090053701 Detectable nucleic acid tag
02/26/2009US20090053700 Optical sorting method
02/26/2009US20090053697 Pharmacological Applications of Mitochondrial DNA Assays
02/26/2009US20090053696 Biomarker For Heart Failure
02/26/2009US20090053695 Gene Marker and Use Thereof
02/26/2009US20090053694 Photochemically Amplified Bioassay
02/26/2009US20090053692 Detection of hiv-1 by nucleic acid amplification
02/26/2009US20090053690 Surface chemistry and deposition techniques
02/26/2009US20090053689 Device for processing a biological and/or chemical sample and method of using the same
02/26/2009US20090053688 method and device for ultrasound assisted particle agglutination assay
02/26/2009US20090053394 Manufacturing method and evaluating method of magnetic recording medium
02/26/2009US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions
02/26/2009US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN)
02/26/2009US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
02/26/2009US20090053265 Antigenic peptides and their use
02/26/2009US20090053258 Assays for diagnosis of tuberculosis and uses thereof
02/26/2009US20090053253 Process for the measurement of the potency of glatiramer acetate
02/26/2009US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
02/26/2009US20090053243 Anti-IgSF4 Antibody and Utilization of the Same
02/26/2009US20090053239 ACACS As Modifiers of the IGF Pathway and Methods of Use
02/26/2009US20090053237 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
02/26/2009US20090053232 Modulation of synaptogenesis
02/26/2009US20090053231 Optical Disc Apparatus
02/26/2009US20090053228 Lawsonia intracellularis subunit vaccines
02/26/2009US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics
02/26/2009US20090053224 Lox and loxl2 inhibitors and uses thereof
02/26/2009US20090053215 Cytotoxicity mediation of cells evidencing surface expression of CD63
02/26/2009US20090053207 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas
02/26/2009US20090053204 Functional Genomic Pore Assay For Mixed Cell Populations
02/26/2009US20090053195 Biomarkers for acute graft rejection
02/26/2009US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells
02/26/2009US20090053110 Multifunctional earphone and alcohol monitoring system using the same
02/26/2009US20090053106 Autonomous microfluidic apparatus
02/26/2009US20090053071 System and method for reducing air bubbles in a fluid delivery line
02/26/2009US20090050854 Organic Species that Facilitate Charge Transfer to or from Nanostructures
02/26/2009US20090050826 Method and device for the contactless detection of flat objects
02/26/2009US20090050553 Instrument for separating blood and apparatus for separating blood
02/26/2009US20090049935 Stabilized milnacipran formulation
02/26/2009US20090049916 Detection of defects in welded structures
02/26/2009US20090049892 Analytical system and method of use
02/26/2009US20090049890 Multi-moduled nanoparticle-structured sensing array and pattern recognition device for detection of acetone in breath
02/26/2009DE202007014923U1 Wannenförmiges Behältnis für optisch zu analysierende Testobjekte und Herstellungsvorrichtung dafür A trench-shaped container for visually analyzed test objects and manufacturing apparatus therefor
02/26/2009DE112007001030T5 Amyloid-ß-Fibrillogenese-inhibierendes Peptid Amyloid-beta fibrillogenesis-inhibiting peptide
02/26/2009DE102007048182B3 Measuring arrangement for detecting oil e.g. mineral oil, level in internal combustion engine of passenger car, has evaluation and control unit determining oil level by comparing pressure difference with preset difference value
02/26/2009DE102007039539A1 Bar-shaped wood component non-destructively testing method, involves measuring hysteresis curve, determining characteristic value, and outputting signal when characteristic value exceeds given desired value
02/26/2009DE102007038657A1 Device for light-optical track detection of nitroaromatic-based explosive material, comprises a light source, optical sensors and a selective adsorbent receptor film formed on an optical surface
02/26/2009DE102007035770A1 Liquid i.e. engine oil, viscosity and/or density determining device for motor vehicle, has side pieces connected with piezoelectric device and partially overlapping during oscillation such that gap is formed between side pieces
02/26/2009DE102006031623B4 Verfahren zur Verbesserung der Wärmeübertragung bei Wärme- und Kältequellen im Boden A method for improving the heat transfer in heat and cold sources in the soil
02/26/2009DE102005011003B9 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors
02/26/2009DE102005002672B4 Verfahren zur schnellen Differenzierung von Mikroorganismen auf Subspezies-Ebene mittels MALDI-TOF MS A method for the rapid differentiation of microorganisms on subspecies level by MALDI-TOF MS
02/26/2009CA2734549A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
02/26/2009CA2697656A1 Non-specific reaction inhibitor
02/26/2009CA2697294A1 Interaction screening methods, systems and devices
02/26/2009CA2697045A1 Improved alzheimer's diagnosis
02/26/2009CA2697024A1 Bilayers
02/26/2009CA2696887A1 Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
02/26/2009CA2696865A1 A process for isolation and purification of a target protein free of prion protein (prpsc)